Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06459791

Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid (AVATAR)

Led by Institut Curie · Updated on 2026-01-29

110

Participants Needed

3

Research Sites

199 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

A biopsy of a tumor lesion (breast or other localisation) will be performed for processing to establish avatars (patient-derived organoids -PDO). A personalized tumorogram for each patient will be provided, based on the results of the drug screening (= tumor predicted as sensitive, intermediate, resistant or non-evaluable for each drug tested). Patients with an informative tumorogram will receive one of the recommended treatments (line N+1) in the event of tumor progression, administered according to standard procedures and validated at medical meetings specific to each center, and their fate will be monitored.

CONDITIONS

Official Title

Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid (AVATAR)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient over 18 years of age
  • Advanced breast cancer
  • Triple-negative phenotype (HR-/HER2-) or HR+/HER2- after hormone resistance (progression after treatment with hormone therapy + CDK4/6 inhibitor)
  • Tumor measurable according to RECISTv1.1 criteria, accessible to biopsy
  • Performance Status 0-1
Not Eligible

You will not qualify if you...

  • More than 3 lines of chemotherapy in the advanced setting (excluding hormone therapy/CDK4/6 inhibitor)
  • Progressive brain metastases
  • Leptomeningeal metastasis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Institut Curie

Paris, France, 75005

Actively Recruiting

2

Hôpital Saint-Louis - AP-HP Senopole

Paris, France, 75010

Not Yet Recruiting

3

Institut Curie

Saint-Cloud, France, 92210

Actively Recruiting

Loading map...

Research Team

L

Luc CABEL, MD

CONTACT

A

Anne-Sophie Plissonnier

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here